118 related articles for article (PubMed ID: 15352034)
1. The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis.
Braumann C; Henke W; Jacobi CA; Dubiel W
Int J Cancer; 2004 Nov; 112(2):225-30. PubMed ID: 15352034
[TBL] [Abstract][Full Text] [Related]
2. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Bobrich E; Braumann C; Opitz I; Menenakos C; Kristiansen G; Jacobi CA
J Surg Res; 2007 Jan; 137(1):75-82. PubMed ID: 17109891
[TBL] [Abstract][Full Text] [Related]
3. Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.
Nestler G; Schulz HU; Schubert D; Krüger S; Lippert H; Pross M
Surg Endosc; 2005 Feb; 19(2):280-4. PubMed ID: 15870965
[TBL] [Abstract][Full Text] [Related]
4. [Peritoneal instillation of taurolidine and heparin for preventing intraperitoneal tumor growth and trocar metastases in laparoscopic operations in the rat model].
Jacobi CA; Sabat R; Ordemann J; Wenger F; Volk HD; Müller JM
Langenbecks Arch Chir; 1997; 382(4 Suppl 1):S31-6. PubMed ID: 9333705
[TBL] [Abstract][Full Text] [Related]
5. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
Braumann C; Schoenbeck M; Menenakos C; Kilian M; Jacobi CA
Clin Exp Metastasis; 2005; 22(1):77-83. PubMed ID: 16132581
[TBL] [Abstract][Full Text] [Related]
6. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
Walters DK; Muff R; Langsam B; Gruber P; Born W; Fuchs B
Invest New Drugs; 2007 Aug; 25(4):305-12. PubMed ID: 17458504
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
[TBL] [Abstract][Full Text] [Related]
8. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
[TBL] [Abstract][Full Text] [Related]
9. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
10. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
11. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 2001 Sep; 61(18):6816-21. PubMed ID: 11559556
[TBL] [Abstract][Full Text] [Related]
12. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
13. [In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity].
Petrovic L; Schlegel KA; Ries J; Park J; Diebel E; Schultze-Mosgau S; Wiltfang J
Mund Kiefer Gesichtschir; 2003 Mar; 7(2):102-7. PubMed ID: 12664255
[TBL] [Abstract][Full Text] [Related]
14. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model.
Jacobi CA; Ordemann J; Böhm B; Zieren HU; Sabat R; Müller JM
Am J Surg; 1997 Sep; 174(3):359-63. PubMed ID: 9324156
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model.
Braumann C; Jacobi CA; Rogalla S; Menenakos C; Fuehrer K; Trefzer U; Hofmann M
J Surg Res; 2007 Dec; 143(2):372-8. PubMed ID: 17612567
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat.
Jacobi CA; Peter FJ; Wenger FA; Ordemann J; Müller JM
Dig Surg; 1999; 16(5):393-9. PubMed ID: 10567800
[TBL] [Abstract][Full Text] [Related]
18. Taurolidine--a new drug with anti-tumor and anti-angiogenic effects.
Jacobi CA; Menenakos C; Braumann C
Anticancer Drugs; 2005 Oct; 16(9):917-21. PubMed ID: 16162968
[TBL] [Abstract][Full Text] [Related]
19. Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
Braumann C; Ordemann J; Kilian M; Wenger FA; Jacobi CA
Clin Exp Metastasis; 2003; 20(5):387-94. PubMed ID: 14524527
[TBL] [Abstract][Full Text] [Related]
20. The effect of taurolidine on brain tumor cells.
Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
